{
    "2FJ.F": {
        "short_name": "PIERREL S.P.A.",
        "long_name": "Pierrel S.p.A.",
        "summary": "Pierrel S.p.A. provides contract manufacturing services to the life science, biopharma, and pharmaceutical industries worldwide. The company is involved in the development of various types of drugs, such as tube vials, bottles, ampoules, drops, sprays, syrups, gels, creams, ointments, and tablets; and production of active ingredients, including active substances and pharmaceutical formulations, as well as develops and manufactures dental anesthetics under the Orabloc brand name. It also engages in the development, registration, and licensing of new drugs and medical devices. Pierrel S.p.A. is based in Capua, Italy.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - General",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Italy",
        "state": "CE",
        "city": "Capua",
        "zipcode": "81043",
        "website": "http://www.pierrelgroup.com",
        "market_cap": "Small Cap"
    },
    "34D.F": {
        "short_name": "DIASORIN S.P.A.  EO 1",
        "long_name": "DiaSorin S.p.A.",
        "summary": "DiaSorin S.p.A. develops, manufactures, and distributes immunodiagnostics and molecular diagnostics tests for private and hospital microbiology laboratories worldwide. The company offers testing kits for infectious diseases, such as gastrointestinal infections, bone and mineral metabolism, endocrinology, hypertension, oncology, onco-hematology, and autoimmunity. It also provides various immunodiagnostic platforms, including LIAISON XL, LIAISON XS, LIAISON QuantiFERON TB Gold PLUS, LIAISON Elastase-1, and LIAISON MDX. The company sells its products directly, as well as through an international network of independent distributors. DiaSorin S.p.A. has collaboration with QIAGEN to develop an ultra-sensitive diagnostic test for Lyme disease. The company was founded in 1968 and is headquartered in Saluggia, Italy.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Diagnostics & Research",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Italy",
        "state": "VC",
        "city": "Saluggia",
        "zipcode": "13040",
        "website": "http://www.diasoringroup.com",
        "market_cap": "Mid Cap"
    },
    "6I7.F": {
        "short_name": "LABOMAR S.P.A.",
        "long_name": "Labomar S.p.A.",
        "summary": "Labomar S.p.A. researches, develops, manufactures, and sells food supplements, medical devices, cosmetics, and pharmaceutical products in Italy, France, Poland, Spain, North America, and internationally. It offers food supplements for various therapeutic areas, including immune systems, gastroenterology, cough and cold, neurology, oncology, eyesight wellness, sport, dermatology, inside beauty, cardiology, orthopedics, pediatrics, detoxing, and metabolic syndrome; and vitamins, minerals, and antioxidants. The company also provides medical devices for the use in gynaecology, cough and cold, gastroenterology, wound healing, metabolic syndrome, proctology, detoxing, and oral wound care therapeutic areas; and foods for special medical purposes, such as gastroenterology, endocrinology, and dysphagia. In addition, it offers cosmetics for inside beauty, skin cleanser, skincare, haircare, oral wound care, sun care, dermatology, acne rosacea, acne, atopic dertmatitis, and bruises therapeutic areas; and probiotic food supplements. Further, the company provides contract development and manufacturing services. Labomar S.p.A. offers its products in the form of tablets, capsules, liquids, powders, and semi solids. It has a commercial agreement with Bayer for the development and production of the references in various pharmaceutical flavors and forms. The company was founded in 1998 and is headquartered in Istrana, Italy. Labomar S.p.A. is a subsidiary of LBM Holding S.r.l.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Italy",
        "state": "TV",
        "city": "Istrana",
        "zipcode": "31036",
        "website": "http://labomar.com",
        "market_cap": "Small Cap"
    },
    "761.F": {
        "short_name": "PHARMANUTRA S.P.A.",
        "long_name": "Pharmanutra S.p.A.",
        "summary": "Pharmanutra S.p.A., a pharmaceutical company, engages in the research, design, development, and marketing of nutraceutical supplements and medical devices in Europe, Asia, the United States, and Africa. The company also manufactures and distributes active ingredients for the pharmaceutical, food, and dietary supplement industry; and develops and distributes drugs, medical devices, OTC products, and nutritional supplements with focus on the pediatric area. Its products primarily include Apportal, Sideral Folic 30, UltraMag, Cetilar, Gestalys DHA, Sideral Forte, CardioSideral, Bonecal, Novomega, and Dikappa2. The company distributes and sells its products through sales representatives and wholesalers to pharmacies and para-pharmacies. Pharmanutra S.p.A. was founded in 2003 and is based in Pisa, Italy.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Italy",
        "state": "PI",
        "city": "Pisa",
        "zipcode": "56122",
        "website": "http://www.pharmanutra.it",
        "market_cap": "Small Cap"
    },
    "ABS.MI": {
        "short_name": "ARTERRA BIOSCIENCE",
        "long_name": "Arterra Bioscience S.p.A.",
        "summary": "Arterra Bioscience S.p.A., a research-based biotech company, engages in the research and development of various ingredients and natural solutions. It develops technological platforms, extraction processes, and raw materials for use in the cosmetics, agriculture, and nutraceutics sectors. The company was founded in 2003 and is based in Naples, Italy.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "MIL",
        "market": "it_market",
        "country": "Italy",
        "state": "NA",
        "city": "Napoli",
        "zipcode": "80142",
        "website": "http://www.arterrabio.it",
        "market_cap": "Small Cap"
    },
    "AMP.MI": {
        "short_name": "AMPLIFON",
        "long_name": "Amplifon S.p.A.",
        "summary": "Amplifon S.p.A. provides hearing products and services that help people rediscover various emotions of sound. The company also offers fitting of customized products. It operates through a network of approximately 11,000 points of sale in 28 countries and 5 continents. The company also sells its products through 1,700 affiliates and franchisees. It has operations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific region. The company was founded in 1950 and is headquartered in Milan, Italy.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Instruments & Supplies",
        "exchange": "MIL",
        "market": "it_market",
        "country": "Italy",
        "state": "MI",
        "city": "Milan",
        "zipcode": "20141",
        "website": "http://corporate.amplifon.com",
        "market_cap": "Mid Cap"
    },
    "AMP.VI": {
        "short_name": "AMPLIFON SPA",
        "long_name": "Amplifon S.p.A.",
        "summary": "Amplifon S.p.A. provides hearing products and services that help people rediscover various emotions of sound. The company also offers fitting of customized products. It operates through a network of approximately 11,000 points of sale in 28 countries and 5 continents. The company also sells its products through 1,700 affiliates and franchisees. It has operations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific region. The company was founded in 1950 and is headquartered in Milan, Italy.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Instruments & Supplies",
        "exchange": "VIE",
        "market": "at_market",
        "country": "Italy",
        "state": "MI",
        "city": "Milan",
        "zipcode": "20141",
        "website": "http://corporate.amplifon.com",
        "market_cap": "Mid Cap"
    },
    "AXNA.F": {
        "short_name": "AMPLIFON S.P.A.  EO-,02",
        "long_name": "Amplifon S.p.A.",
        "summary": "Amplifon S.p.A. provides hearing products and services that help people rediscover various emotions of sound. The company also offers fitting of customized products. It operates through a network of approximately 11,000 points of sale in 28 countries and 5 continents. The company also sells its products through 1,700 affiliates and franchisees. It has operations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific region. The company was founded in 1950 and is headquartered in Milan, Italy.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Instruments & Supplies",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Italy",
        "state": "MI",
        "city": "Milan",
        "zipcode": "20141",
        "website": "http://corporate.amplifon.com",
        "market_cap": "Mid Cap"
    },
    "CSP.F": {
        "short_name": "CASSIOPEA S.P.A.  EO 1",
        "long_name": "Cassiopea S.p.A.",
        "summary": "Cassiopea S.p.A., a clinical-stage specialty pharmaceutical company, focuses on developing and commercializing medical dermatology products worldwide. It offers Winlevi, an antiandrogen, which has completed Phase III clinical trial for the topical treatment of acne; Breezula, a topical antiandrogen that is in Phase II clinical trial to treat androgenic alopecia; CB-06-01, a topical antibiotic, which is in Phase II clinical trial for the treatment of acne, including strains resistant to other antibiotics; and CB-06-02, a novel integrin activator that has completed Phase II clinical trial to treat genital warts. The company was formerly known as Cosmo Dermatos S.r.l. Cassiopea S.p.A. was founded in 2013 and is based in Lainate, Italy.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Italy",
        "state": "MI",
        "city": "Lainate",
        "zipcode": "20020",
        "website": "http://www.cassiopea.com",
        "market_cap": "Small Cap"
    },
    "DIA.MI": {
        "short_name": "DIASORIN",
        "long_name": "DiaSorin S.p.A.",
        "summary": "DiaSorin S.p.A. develops, manufactures, and distributes immunodiagnostics and molecular diagnostics tests for private and hospital microbiology laboratories worldwide. The company offers testing kits for infectious diseases, such as gastrointestinal infections, bone and mineral metabolism, endocrinology, hypertension, oncology, onco-hematology, and autoimmunity. It also provides various immunodiagnostic platforms, including LIAISON XL, LIAISON XS, LIAISON QuantiFERON TB Gold PLUS, LIAISON Elastase-1, and LIAISON MDX. The company sells its products directly, as well as through an international network of independent distributors. DiaSorin S.p.A. has collaboration with QIAGEN to develop an ultra-sensitive diagnostic test for Lyme disease. The company was founded in 1968 and is headquartered in Saluggia, Italy.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Diagnostics & Research",
        "exchange": "MIL",
        "market": "it_market",
        "country": "Italy",
        "state": "VC",
        "city": "Saluggia",
        "zipcode": "13040",
        "website": "http://www.diasoringroup.com",
        "market_cap": "Mid Cap"
    },
    "DIAS.VI": {
        "short_name": "DIASORIN SPA",
        "long_name": "DiaSorin S.p.A.",
        "summary": "DiaSorin S.p.A. develops, manufactures, and distributes immunodiagnostics and molecular diagnostics tests for private and hospital microbiology laboratories worldwide. The company offers testing kits for infectious diseases, such as gastrointestinal infections, bone and mineral metabolism, endocrinology, hypertension, oncology, onco-hematology, and autoimmunity. It also provides various immunodiagnostic platforms, including LIAISON XL, LIAISON XS, LIAISON QuantiFERON TB Gold PLUS, LIAISON Elastase-1, and LIAISON MDX. The company sells its products directly, as well as through an international network of independent distributors. DiaSorin S.p.A. has collaboration with QIAGEN to develop an ultra-sensitive diagnostic test for Lyme disease. The company was founded in 1968 and is headquartered in Saluggia, Italy.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Diagnostics & Research",
        "exchange": "VIE",
        "market": "at_market",
        "country": "Italy",
        "state": "VC",
        "city": "Saluggia",
        "zipcode": "13040",
        "website": "http://www.diasoringroup.com",
        "market_cap": "Mid Cap"
    },
    "DSRLF": {
        "short_name": "DIASORIN SPA",
        "long_name": "DiaSorin S.p.A.",
        "summary": "DiaSorin S.p.A. develops, manufactures, and distributes immunodiagnostics and molecular diagnostics tests for private and hospital microbiology laboratories worldwide. The company offers testing kits for infectious diseases, such as gastrointestinal infections, bone and mineral metabolism, endocrinology, hypertension, oncology, onco-hematology, and autoimmunity. It also provides various immunodiagnostic platforms, including LIAISON XL, LIAISON XS, LIAISON QuantiFERON TB Gold PLUS, LIAISON Elastase-1, and LIAISON MDX. The company sells its products directly, as well as through an international network of independent distributors. DiaSorin S.p.A. has collaboration with QIAGEN to develop an ultra-sensitive diagnostic test for Lyme disease. The company was founded in 1968 and is headquartered in Saluggia, Italy.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Diagnostics & Research",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Italy",
        "state": "VC",
        "city": "Saluggia",
        "zipcode": "13040",
        "website": "http://www.diasoringroup.com",
        "market_cap": "Mid Cap"
    },
    "EE51.F": {
        "short_name": "EL.EN. S.P.A.  EO 0,13",
        "long_name": "EL.En. S.p.A.",
        "summary": "EL.En. S.p.A. engages in the research and development, manufacture, distribution, and sale of laser systems in Italy, Europe, and internationally. The company offers medical laser equipment for use in the fields of physiotherapy, orthopedics, traumatology, rheumatology, dermatology, sports and rehabilitative medicine, surgery, aesthetics, and art; and laser sources and systems for cutting, welding, marking, and engraving on countless materials. It also provides laser sources that include liquid, solid, semiconductor, and gas; and after-sales services, such as supplying of spare parts, as well as consulting and technical assistance services. The company was founded in 1981 and is headquartered in Calenzano, Italy.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Italy",
        "state": "FI",
        "city": "Calenzano",
        "zipcode": "50041",
        "website": "http://www.elengroup.com",
        "market_cap": "Small Cap"
    },
    "ELN.MI": {
        "short_name": "EL.EN.",
        "long_name": "EL.En. S.p.A.",
        "summary": "EL.En. S.p.A. engages in the research and development, manufacture, distribution, and sale of laser systems in Italy, Europe, and internationally. The company offers medical laser equipment for use in the fields of physiotherapy, orthopedics, traumatology, rheumatology, dermatology, sports and rehabilitative medicine, surgery, aesthetics, and art; and laser sources and systems for cutting, welding, marking, and engraving on countless materials. It also provides laser sources that include liquid, solid, semiconductor, and gas; and after-sales services, such as supplying of spare parts, as well as consulting and technical assistance services. The company was founded in 1981 and is headquartered in Calenzano, Italy.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "MIL",
        "market": "it_market",
        "country": "Italy",
        "state": "FI",
        "city": "Calenzano",
        "zipcode": "50041",
        "website": "http://www.elengroup.com",
        "market_cap": "Small Cap"
    },
    "EUK.MI": {
        "short_name": "EUKEDOS",
        "long_name": "EuKedos S.p.A.",
        "summary": "EuKedos S.p.A. provides managed and long-term care services in Italy. The company offers residential social care services to elderly, self-sufficient, or incapacitated adults. It manages healthcare and assistance residences with 1,345 beds in the North and Central Italy, primarily located in Lombardy, Piedmont, Abruzzo, Valle D'Aosta, and Emilia Romagna. EuKedos S.p.A. is based in Florence, Italy.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "MIL",
        "market": "it_market",
        "country": "Italy",
        "state": "FI",
        "city": "Florence",
        "zipcode": "50125",
        "website": "http://www.eukedos.it",
        "market_cap": "Small Cap"
    },
    "FCM.MI": {
        "short_name": "FRIULCHEM",
        "long_name": "Friulchem S.p.A.",
        "summary": "Friulchem S.p.A. engages in the research, development, and production of original and generic pharmaceutical products for human and veterinary fields in Italy. It offers generic cosmoceuticals and food supplements; chewable cubes for animals; and cosmetic products for pigmentation disorders. The company is based in Milan, Italy.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "MIL",
        "market": "it_market",
        "country": "Italy",
        "state": "MI",
        "city": "Milan",
        "zipcode": "20149",
        "website": "http://www.friulchem.com",
        "market_cap": "Small Cap"
    },
    "FF.MI": {
        "short_name": "FINE FOODS & PHARMACEUTICALS NT",
        "long_name": "Fine Foods & Pharmaceuticals N.T.M. S.p.A.",
        "summary": "Fine Foods & Pharmaceuticals N.T.M. S.p.A. engages in the contract development and manufacturing of pharmaceuticals, nutraceuticals, and medical devices. Its pharmaceutical products include powders and granules, tablets, coated tablets, and hard gelatin capsules; and nutraceutical products comprise soluble and effervescent powders and granules, coated tablets, and hard gelatin capsules, as well as soluble, effervescent, and chewable tablets. The company also develops and manufactures medical devices for gastrointestinal treatment, oral and throat treatment, and weight management. Fine Foods & Pharmaceuticals N.T.M. S.p.A. was founded in 1985 and is based in Verdellino, Italy.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "MIL",
        "market": "it_market",
        "country": "Italy",
        "state": "BG",
        "city": "Verdellino",
        "zipcode": "24040",
        "website": "http://www.finefoods.it",
        "market_cap": "Small Cap"
    },
    "GHC.F": {
        "short_name": "GAROFALO HEALTH CARE",
        "long_name": "Garofalo Health Care S.p.A.",
        "summary": "Garofalo Health Care S.p.A. operates healthcare centers in Italy. It offers services in the areas of high-complexity surgery, medium- and low-complexity surgery, emergency surgery, medicine, clinical and interventional cardiology, and extended and intensive care units, as well as motor, neurological, cardiac, and nutritional rehabilitation. The company also operates centers for patients in coma and persistent vegetative states; and psychiatric and diagnostic centers. It operates 19 healthcare facilities located in Piedmont, Veneto, Tuscany, Emilia-Romagna, Lazio, and Liguria. The company is based in Rome, Italy.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Italy",
        "state": "RM",
        "city": "Rome",
        "zipcode": "00196",
        "website": "http://www.garofalohealthcare.com",
        "market_cap": "Small Cap"
    },
    "GHC.MI": {
        "short_name": "GAROFALO HEALTH CARE",
        "long_name": "Garofalo Health Care S.p.A.",
        "summary": "Garofalo Health Care S.p.A. operates healthcare centers in Italy. It offers services in the areas of high-complexity surgery, medium- and low-complexity surgery, emergency surgery, medicine, clinical and interventional cardiology, and extended and intensive care units, as well as motor, neurological, cardiac, and nutritional rehabilitation. The company also operates centers for patients in coma and persistent vegetative states; and psychiatric and diagnostic centers. It operates 19 healthcare facilities located in Piedmont, Veneto, Tuscany, Emilia-Romagna, Lazio, and Liguria. The company is based in Rome, Italy.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "MIL",
        "market": "it_market",
        "country": "Italy",
        "state": "RM",
        "city": "Rome",
        "zipcode": "00196",
        "website": "http://www.garofalohealthcare.com",
        "market_cap": "Small Cap"
    },
    "HI.MI": {
        "short_name": "HEALTH ITALIA",
        "long_name": "Health Italia S.p.A.",
        "summary": "Health Italia S.p.A. promotes supplementary health plans and solutions for the prevention and well-being of the individual in Italy. The company offers administrative, settlement, IT, and consultancy services to mutual aid companies, health funds, and assistance funds. It also manages corporate welfare plans and carries out training activities. The company was formerly known as Health Holding Group S.p.A. and changed its name to Health Italia S.p.A. in 2015. The company was founded in 2001 and is headquartered in Formello, Italy.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Healthcare Plans",
        "exchange": "MIL",
        "market": "it_market",
        "country": "Italy",
        "state": "RM",
        "city": "Formello",
        "zipcode": "00060",
        "website": "http://www.healthitalia.it",
        "market_cap": "Small Cap"
    },
    "IIG.MI": {
        "short_name": "ITALIA INDEPENDENT",
        "long_name": "Italia Independent Group S.p.A.",
        "summary": "Italia Independent Group S.p.A. manufactures and distributes sunglasses and reading glass frames in Italy and internationally. It offers lifestyle products and eyewear under the Italia Independent brand name; and communication services through its Independent Ideas agency. The company was formerly known as LA S.r.l. Italia Independent Group S.p.A. was incorporated in 2006 and is based in Turin, Italy.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Instruments & Supplies",
        "exchange": "MIL",
        "market": "it_market",
        "country": "Italy",
        "state": "TO",
        "city": "Turin",
        "zipcode": null,
        "website": "http://www.italiaindependentgroup.com",
        "market_cap": "Small Cap"
    },
    "KIP.MI": {
        "short_name": "KOLINPHARMA",
        "long_name": "Kolinpharma S.p.A.",
        "summary": "Kolinpharma S.p.A. operates as a nutraceuticals company. It offers gynecological and orthopedic products. The company was founded in 2013 and is based in Lainate, Italy.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "MIL",
        "market": "it_market",
        "country": "Italy",
        "state": "MI",
        "city": "Lainate",
        "zipcode": "20020",
        "website": "http://www.kolinpharma.com",
        "market_cap": "Small Cap"
    },
    "LBM.MI": {
        "short_name": "LABOMAR",
        "long_name": "Labomar S.p.A.",
        "summary": "Labomar S.p.A. researches, develops, manufactures, and sells food supplements, medical devices, cosmetics, and pharmaceutical products in Italy, France, Poland, Spain, North America, and internationally. It offers food supplements for various therapeutic areas, including immune systems, gastroenterology, cough and cold, neurology, oncology, eyesight wellness, sport, dermatology, inside beauty, cardiology, orthopedics, pediatrics, detoxing, and metabolic syndrome; and vitamins, minerals, and antioxidants. The company also provides medical devices for the use in gynaecology, cough and cold, gastroenterology, wound healing, metabolic syndrome, proctology, detoxing, and oral wound care therapeutic areas; and foods for special medical purposes, such as gastroenterology, endocrinology, and dysphagia. In addition, it offers cosmetics for inside beauty, skin cleanser, skincare, haircare, oral wound care, sun care, dermatology, acne rosacea, acne, atopic dertmatitis, and bruises therapeutic areas; and probiotic food supplements. Further, the company provides contract development and manufacturing services. Labomar S.p.A. offers its products in the form of tablets, capsules, liquids, powders, and semi solids. It has a commercial agreement with Bayer for the development and production of the references in various pharmaceutical flavors and forms. The company was founded in 1998 and is headquartered in Istrana, Italy. Labomar S.p.A. is a subsidiary of LBM Holding S.r.l.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "MIL",
        "market": "it_market",
        "country": "Italy",
        "state": "TV",
        "city": "Istrana",
        "zipcode": "31036",
        "website": "http://labomar.com",
        "market_cap": "Small Cap"
    },
    "MLLAB.PA": {
        "short_name": "MEDIA LAB",
        "long_name": "Media Lab S.p.A.",
        "summary": "Media Lab S.p.A. provides IT solutions for dental sector. It offers Implant 3D, an implant planning software that allows the user to perform three-dimensional implant simulation directly on personal computer; GuideDesign, a module of the Implant 3D software, which enables the design of guides for performing implant-prosthetic intervention in guided surgery; ConfiDent, an integrated management software of the dental office; ConfiDent Cloud, a cloud solution; and MiaFirma, a graphical signature for ConfiDent. The company also provides ConfiDea, an accounting software; electronic invoicing solutions; and health card readers. Media Lab S.p.A. was founded in 1994 and is based in Milan, Italy.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Health Information Services",
        "exchange": "PAR",
        "market": "fr_market",
        "country": "Italy",
        "state": "MI",
        "city": "Milan",
        "zipcode": "20124",
        "website": "http://www.mlsw.com",
        "market_cap": "Small Cap"
    },
    "NP5.F": {
        "short_name": "NEWRON PHARMACEUT. EO-,20",
        "long_name": "Newron Pharmaceuticals S.p.A.",
        "summary": "Newron Pharmaceuticals S.p.A., a clinical stage biopharmaceutical company, focuses on the research and development, manufacture, and distribution of therapies for the treatment of central and peripheral nervous system, and pain in Italy and the United States. The company offers Xadago (safinamide) for the treatment of Parkinson's disease. Its product pipeline comprises Evenamide, a first add-on therapy for the treatment of patients with positive symptoms of schizophrenia; and Ralfinamide for patients with specific rare pain indications. Newron Pharmaceuticals S.p.A. was founded in 1999 and is headquartered in Bresso, Italy.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Italy",
        "state": "MI",
        "city": "Bresso",
        "zipcode": "20091",
        "website": "http://www.newron.com",
        "market_cap": "Small Cap"
    },
    "NWPHF": {
        "short_name": "NEWRON PHARMACEUTICALS S.P.A.",
        "long_name": "Newron Pharmaceuticals S.p.A.",
        "summary": "Newron Pharmaceuticals S.p.A., a clinical stage biopharmaceutical company, focuses on the research and development, manufacture, and distribution of therapies for the treatment of central and peripheral nervous system, and pain in Italy and the United States. The company offers Xadago (safinamide) for the treatment of Parkinson's disease. Its product pipeline comprises Evenamide, a first add-on therapy for the treatment of patients with positive symptoms of schizophrenia; and Ralfinamide for patients with specific rare pain indications. Newron Pharmaceuticals S.p.A. was founded in 1999 and is headquartered in Bresso, Italy.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Italy",
        "state": "MI",
        "city": "Bresso",
        "zipcode": "20091",
        "website": "http://www.newron.com",
        "market_cap": "Small Cap"
    },
    "NWRN.SW": {
        "short_name": "NEWRON PHARMA N",
        "long_name": "Newron Pharmaceuticals S.p.A.",
        "summary": "Newron Pharmaceuticals S.p.A., a clinical stage biopharmaceutical company, focuses on the research and development, manufacture, and distribution of therapies for the treatment of central and peripheral nervous system, and pain in Italy and the United States. The company offers Xadago (safinamide) for the treatment of Parkinson's disease. Its product pipeline comprises Evenamide, a first add-on therapy for the treatment of patients with positive symptoms of schizophrenia; and Ralfinamide for patients with specific rare pain indications. Newron Pharmaceuticals S.p.A. was founded in 1999 and is headquartered in Bresso, Italy.",
        "currency": "CHF",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "EBS",
        "market": "ch_market",
        "country": "Italy",
        "state": "MI",
        "city": "Bresso",
        "zipcode": "20091",
        "website": "http://www.newron.com",
        "market_cap": "Small Cap"
    },
    "PHIL.MI": {
        "short_name": "PHILOGEN",
        "long_name": "Philogen S.p.A.",
        "summary": "Philogen S.p.A., a biotechnology company, develops biopharmaceuticals for the treatment of angiogenesis-related disorders. The company focuses on developing immunocytokines for oncology and in chronic inflammatory diseases. It is developing NIDLEGYTM (DAROMUN), an immunocytokine product used as a neoadjuvant intralesional treatment for melanoma patients with locoregional disease that is in phase III clinical trial for intralesional application and phase II clinical trial to treat non-melanoma skin cancer; FIBROMUN, a human immunomodulatory product consisting of the human anti-EDB antibody L19 to treat soft tissue sarcoma, leiomyosarcoma, and glioma; and DARLEUKIN (L19IL2), a human immunostimulatory product consisting of the human anti-EDB antibody L19, which is in phase II clinical trial for the treatment of metastatic non-small cell lung cancer. The company is also developing DODEKIN, a human immunostimulatory product that comprises vascular targeting antibody fused to the human cytokine interleukin-12 that is in phase I clinical trial to treat advanced solid carcinomas; DEKAVIL (F8IL10), an anti-inflammatory product, which is in phase 2 clinical trial for the treatment of chronic inflammation; Onco IX (PHC-102), a 99mTc labelled small molecule radiotracer for the non-invasive detection of carbonic anhydrase IX (CAIX) expressing solid tumors that is in phase 1 clinical trial; and OncoFAP, a small molecule radiotracer for the non-invasive detection of various metastatic solid tumors targeting fibroblast activation protein, which is in phase 1 clinical trial. Philogen S.p.A. was founded in 1996 and is based in Sovicille, Italy.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "MIL",
        "market": "it_market",
        "country": "Italy",
        "state": "SI",
        "city": "Sovicille",
        "zipcode": "53018",
        "website": "http://www.philogen.com",
        "market_cap": null
    },
    "PHN.MI": {
        "short_name": "PHARMANUTRA",
        "long_name": "Pharmanutra S.p.A.",
        "summary": "Pharmanutra S.p.A., a pharmaceutical company, engages in the research, design, development, and marketing of nutraceutical supplements and medical devices in Europe, Asia, the United States, and Africa. The company also manufactures and distributes active ingredients for the pharmaceutical, food, and dietary supplement industry; and develops and distributes drugs, medical devices, OTC products, and nutritional supplements with focus on the pediatric area. Its products primarily include Apportal, Sideral Folic 30, UltraMag, Cetilar, Gestalys DHA, Sideral Forte, CardioSideral, Bonecal, Novomega, and Dikappa2. The company distributes and sells its products through sales representatives and wholesalers to pharmacies and para-pharmacies. Pharmanutra S.p.A. was founded in 2003 and is based in Pisa, Italy.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "MIL",
        "market": "it_market",
        "country": "Italy",
        "state": "PI",
        "city": "Pisa",
        "zipcode": "56122",
        "website": "http://www.pharmanutra.it",
        "market_cap": "Small Cap"
    },
    "PRL.MI": {
        "short_name": "PIERREL",
        "long_name": "Pierrel S.p.A.",
        "summary": "Pierrel S.p.A. provides contract manufacturing services to the life science, biopharma, and pharmaceutical industries worldwide. The company is involved in the development of various types of drugs, such as tube vials, bottles, ampoules, drops, sprays, syrups, gels, creams, ointments, and tablets; and production of active ingredients, including active substances and pharmaceutical formulations, as well as develops and manufactures dental anesthetics under the Orabloc brand name. It also engages in the development, registration, and licensing of new drugs and medical devices. Pierrel S.p.A. is based in Capua, Italy.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - General",
        "exchange": "MIL",
        "market": "it_market",
        "country": "Italy",
        "state": "CE",
        "city": "Capua",
        "zipcode": "81043",
        "website": "http://www.pierrelgroup.com",
        "market_cap": "Small Cap"
    },
    "RCDTF": {
        "short_name": "RECORDATI",
        "long_name": "Recordati Industria Chimica e Farmaceutica S.p.A.",
        "summary": "Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, marketing, and sale of pharmaceuticals worldwide. The company offers pharmaceuticals in various therapeutic areas, including cardiovascular, dermatology, over the counter/non-prescription pharmaceuticals, urology, anti-infectives, central nervous system, gastrointestinal, gynecology and obstetrics, musculo-skeletal disorders and analgesia, nutrition and related products, cosmetics, dietary supplements, medical devices, allergy, endocrinology, respiratory, pain management/inflammation, generics, antipyretics and cold preparations, and oncology, as well as ear, nose, and throat. It also provides pharmaceutical chemicals, such as chemical syntheses, active pharmaceutical ingredients, and intermediates. The company was founded in 1926 and is headquartered in Milan, Italy. Recordati Industria Chimica e Farmaceutica S.p.A. is a subsidiary of Fimei - Finanziaria Industriale Mobiliare ed Immobiliare S.P.A.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - General",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Italy",
        "state": "MI",
        "city": "Milan",
        "zipcode": "20148",
        "website": "http://www.recordati.com",
        "market_cap": "Large Cap"
    },
    "REC.MI": {
        "short_name": "RECORDATI ORD",
        "long_name": "Recordati Industria Chimica e Farmaceutica S.p.A.",
        "summary": "Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, marketing, and sale of pharmaceuticals worldwide. The company offers pharmaceuticals in various therapeutic areas, including cardiovascular, dermatology, over the counter/non-prescription pharmaceuticals, urology, anti-infectives, central nervous system, gastrointestinal, gynecology and obstetrics, musculo-skeletal disorders and analgesia, nutrition and related products, cosmetics, dietary supplements, medical devices, allergy, endocrinology, respiratory, pain management/inflammation, generics, antipyretics and cold preparations, and oncology, as well as ear, nose, and throat. It also provides pharmaceutical chemicals, such as chemical syntheses, active pharmaceutical ingredients, and intermediates. The company was founded in 1926 and is headquartered in Milan, Italy. Recordati Industria Chimica e Farmaceutica S.p.A. is a subsidiary of Fimei - Finanziaria Industriale Mobiliare ed Immobiliare S.P.A.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - General",
        "exchange": "MIL",
        "market": "it_market",
        "country": "Italy",
        "state": "MI",
        "city": "Milan",
        "zipcode": "20148",
        "website": "http://www.recordati.com",
        "market_cap": "Large Cap"
    },
    "REC.VI": {
        "short_name": "RECORDATI SPA",
        "long_name": "Recordati Industria Chimica e Farmaceutica S.p.A.",
        "summary": "Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, marketing, and sale of pharmaceuticals worldwide. The company offers pharmaceuticals in various therapeutic areas, including cardiovascular, dermatology, over the counter/non-prescription pharmaceuticals, urology, anti-infectives, central nervous system, gastrointestinal, gynecology and obstetrics, musculo-skeletal disorders and analgesia, nutrition and related products, cosmetics, dietary supplements, medical devices, allergy, endocrinology, respiratory, pain management/inflammation, generics, antipyretics and cold preparations, and oncology, as well as ear, nose, and throat. It also provides pharmaceutical chemicals, such as chemical syntheses, active pharmaceutical ingredients, and intermediates. The company was founded in 1926 and is headquartered in Milan, Italy. Recordati Industria Chimica e Farmaceutica S.p.A. is a subsidiary of Fimei - Finanziaria Industriale Mobiliare ed Immobiliare S.P.A.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - General",
        "exchange": "VIE",
        "market": "at_market",
        "country": "Italy",
        "state": "MI",
        "city": "Milan",
        "zipcode": "20148",
        "website": "http://www.recordati.com",
        "market_cap": "Large Cap"
    },
    "RER1.F": {
        "short_name": "RECORDATI SPA  EO -,125",
        "long_name": "Recordati Industria Chimica e Farmaceutica S.p.A.",
        "summary": "Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, marketing, and sale of pharmaceuticals worldwide. The company offers pharmaceuticals in various therapeutic areas, including cardiovascular, dermatology, over the counter/non-prescription pharmaceuticals, urology, anti-infectives, central nervous system, gastrointestinal, gynecology and obstetrics, musculo-skeletal disorders and analgesia, nutrition and related products, cosmetics, dietary supplements, medical devices, allergy, endocrinology, respiratory, pain management/inflammation, generics, antipyretics and cold preparations, and oncology, as well as ear, nose, and throat. It also provides pharmaceutical chemicals, such as chemical syntheses, active pharmaceutical ingredients, and intermediates. The company was founded in 1926 and is headquartered in Milan, Italy. Recordati Industria Chimica e Farmaceutica S.p.A. is a subsidiary of Fimei - Finanziaria Industriale Mobiliare ed Immobiliare S.P.A.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - General",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Italy",
        "state": "MI",
        "city": "Milan",
        "zipcode": "20148",
        "website": "http://www.recordati.com",
        "market_cap": "Large Cap"
    },
    "S5U5.F": {
        "short_name": "SAFILO GROUP S.P.A.  EO 5",
        "long_name": "Safilo Group S.p.A.",
        "summary": "Safilo Group S.p.A. engages in the design, production, retail distribution, and wholesale of products for the eyewear market in North America, Europe, the Asia Pacific, and internationally. The company operates through Wholesale and Retail segments. Its brand portfolio comprises a set of own branded products, such as optical frames, sunglasses, sports goggles, and helmets, as well as licensed brands comprising prescription frames and sunglasses. The company offers its products under own brands comprising Carrera, Polaroid, Smith, Safilo, Blenders Eyewear, and Priv\u00c3\u00a9 Revaux, as well as Adensco, Chesterfield, Elasta, and Emozioni; and licensed brands, such as Banana Republic, BOSS, HUGO, David Beckham, Dior, Dior Homme, Elie Saab, Fendi, Fossil, Givenchy, Havaianas, Jimmy Choo, Juicy Couture, Kate Spade, LEVI'S, Liz Claiborne, Love Moschino, Marc Jacobs, Max Mara, Missoni, M Missoni, Moschino, Pierre Cardin, rag&bone, Saks Fifth Avenue, Swatch, Tommy Hilfiger, Tommy Jeans, and Under Armour. It serves opticians, optometrists, ophthalmologists, distribution chains, department stores, specialized retailers, and licensors' own stores, as well as duty free and sports shops. The company sells its products through a network of independent distributor partners. The company was formerly known as Safilo Holding S.p.A. and changed its name to Safilo Group S.p.A. in September 2005. Safilo Group S.p.A. was founded in 1878 and is headquartered in Padua, Italy.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Instruments & Supplies",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Italy",
        "state": "PD",
        "city": "Padua",
        "zipcode": "35129",
        "website": "http://www.safilogroup.com",
        "market_cap": "Small Cap"
    },
    "SAFLF": {
        "short_name": "SAFILO GROUP",
        "long_name": "Safilo Group S.p.A.",
        "summary": "Safilo Group S.p.A. engages in the design, production, retail distribution, and wholesale of products for the eyewear market in North America, Europe, the Asia Pacific, and internationally. The company operates through Wholesale and Retail segments. Its brand portfolio comprises a set of own branded products, such as optical frames, sunglasses, sports goggles, and helmets, as well as licensed brands comprising prescription frames and sunglasses. The company offers its products under own brands comprising Carrera, Polaroid, Smith, Safilo, Blenders Eyewear, and Priv\u00c3\u00a9 Revaux, as well as Adensco, Chesterfield, Elasta, and Emozioni; and licensed brands, such as Banana Republic, BOSS, HUGO, David Beckham, Dior, Dior Homme, Elie Saab, Fendi, Fossil, Givenchy, Havaianas, Jimmy Choo, Juicy Couture, Kate Spade, LEVI'S, Liz Claiborne, Love Moschino, Marc Jacobs, Max Mara, Missoni, M Missoni, Moschino, Pierre Cardin, rag&bone, Saks Fifth Avenue, Swatch, Tommy Hilfiger, Tommy Jeans, and Under Armour. It serves opticians, optometrists, ophthalmologists, distribution chains, department stores, specialized retailers, and licensors' own stores, as well as duty free and sports shops. The company sells its products through a network of independent distributor partners. The company was formerly known as Safilo Holding S.p.A. and changed its name to Safilo Group S.p.A. in September 2005. Safilo Group S.p.A. was founded in 1878 and is headquartered in Padua, Italy.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Medical Instruments & Supplies",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Italy",
        "state": "PD",
        "city": "Padua",
        "zipcode": "35129",
        "website": "http://www.safilogroup.com",
        "market_cap": "Small Cap"
    },
    "SAFLY": {
        "short_name": "SAFILO GROUP",
        "long_name": "Safilo Group S.p.A.",
        "summary": "Safilo Group S.p.A. engages in the design, production, retail distribution, and wholesale of products for the eyewear market in North America, Europe, the Asia Pacific, and internationally. The company operates through Wholesale and Retail segments. Its brand portfolio comprises a set of own branded products, such as optical frames, sunglasses, sports goggles, and helmets, as well as licensed brands comprising prescription frames and sunglasses. The company offers its products under own brands comprising Carrera, Polaroid, Smith, Safilo, Blenders Eyewear, and Priv\u00c3\u00a9 Revaux, as well as Adensco, Chesterfield, Elasta, and Emozioni; and licensed brands, such as Banana Republic, BOSS, HUGO, David Beckham, Dior, Dior Homme, Elie Saab, Fendi, Fossil, Givenchy, Havaianas, Jimmy Choo, Juicy Couture, Kate Spade, LEVI'S, Liz Claiborne, Love Moschino, Marc Jacobs, Max Mara, Missoni, M Missoni, Moschino, Pierre Cardin, rag&bone, Saks Fifth Avenue, Swatch, Tommy Hilfiger, Tommy Jeans, and Under Armour. It serves opticians, optometrists, ophthalmologists, distribution chains, department stores, specialized retailers, and licensors' own stores, as well as duty free and sports shops. The company sells its products through a network of independent distributor partners. The company was formerly known as Safilo Holding S.p.A. and changed its name to Safilo Group S.p.A. in September 2005. Safilo Group S.p.A. was founded in 1878 and is headquartered in Padua, Italy.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Medical Instruments & Supplies",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Italy",
        "state": "PD",
        "city": "Padua",
        "zipcode": "35129",
        "website": "http://www.safilogroup.com",
        "market_cap": "Small Cap"
    },
    "SFL.MI": {
        "short_name": "SAFILO GROUP",
        "long_name": "Safilo Group S.p.A.",
        "summary": "Safilo Group S.p.A. engages in the design, production, retail distribution, and wholesale of products for the eyewear market in North America, Europe, the Asia Pacific, and internationally. The company operates through Wholesale and Retail segments. Its brand portfolio comprises a set of own branded products, such as optical frames, sunglasses, sports goggles, and helmets, as well as licensed brands comprising prescription frames and sunglasses. The company offers its products under own brands comprising Carrera, Polaroid, Smith, Safilo, Blenders Eyewear, and Priv\u00c3\u00a9 Revaux, as well as Adensco, Chesterfield, Elasta, and Emozioni; and licensed brands, such as Banana Republic, BOSS, HUGO, David Beckham, Dior, Dior Homme, Elie Saab, Fendi, Fossil, Givenchy, Havaianas, Jimmy Choo, Juicy Couture, Kate Spade, LEVI'S, Liz Claiborne, Love Moschino, Marc Jacobs, Max Mara, Missoni, M Missoni, Moschino, Pierre Cardin, rag&bone, Saks Fifth Avenue, Swatch, Tommy Hilfiger, Tommy Jeans, and Under Armour. It serves opticians, optometrists, ophthalmologists, distribution chains, department stores, specialized retailers, and licensors' own stores, as well as duty free and sports shops. The company sells its products through a network of independent distributor partners. The company was formerly known as Safilo Holding S.p.A. and changed its name to Safilo Group S.p.A. in September 2005. Safilo Group S.p.A. was founded in 1878 and is headquartered in Padua, Italy.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Instruments & Supplies",
        "exchange": "MIL",
        "market": "it_market",
        "country": "Italy",
        "state": "PD",
        "city": "Padua",
        "zipcode": "35129",
        "website": "http://www.safilogroup.com",
        "market_cap": "Small Cap"
    },
    "SHE.MI": {
        "short_name": "SHEDIR PHARMA GROUP",
        "long_name": "Shedir Pharma Group S.p.A.",
        "summary": "Shedir Pharma Group S.p.A. operators in the medical and pharmaceutical sector in Italy. It engages in the research and development of nutraceuticals, cosmetics, and medical devices. Its product lines include various pharmaceutical forms, including solid forms, such as capsule, softgel, chewable, and swallowable tablets, as well as buccal tablets powders and granules in sachets; liquid forms comprising oral solutions, drops and sprays for oral use, and sublingual and nasal, single-dose vials and douches; and creams and gels for cosmetic use, as well as topical sprays. The company is based in Naples, Italy.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "MIL",
        "market": "it_market",
        "country": "Italy",
        "state": "NA",
        "city": "Naples",
        "zipcode": "80063",
        "website": "http://www.shedirpharma.com",
        "market_cap": "Small Cap"
    },
    "SKIN.SW": {
        "short_name": "CASSIOPEA N",
        "long_name": "Cassiopea S.p.A.",
        "summary": "Cassiopea S.p.A., a clinical-stage specialty pharmaceutical company, focuses on developing and commercializing medical dermatology products worldwide. It offers Winlevi, an antiandrogen, which has completed Phase III clinical trial for the topical treatment of acne; Breezula, a topical antiandrogen that is in Phase II clinical trial to treat androgenic alopecia; CB-06-01, a topical antibiotic, which is in Phase II clinical trial for the treatment of acne, including strains resistant to other antibiotics; and CB-06-02, a novel integrin activator that has completed Phase II clinical trial to treat genital warts. The company was formerly known as Cosmo Dermatos S.r.l. Cassiopea S.p.A. was founded in 2013 and is based in Lainate, Italy.",
        "currency": "CHF",
        "sector": "Healthcare",
        "industry": "Biotechnology",
        "exchange": "EBS",
        "market": "ch_market",
        "country": "Italy",
        "state": "MI",
        "city": "Lainate",
        "zipcode": "20020",
        "website": "http://www.cassiopea.com",
        "market_cap": "Small Cap"
    }
}